PHI with Periaxial encephalitis
How does this condition affect your private health insurance?
Encephalitis periaxialis diffusa, commonly known as Schilder's disease, is an exceedingly rare and severe inflammatory demyelinating disorder primarily affecting the central nervous system. It involves extensive loss of myelin in the brain's white matter, typically presenting as large, bilateral, but often asymmetric plaques. Symptoms are diverse, depending on the affected brain regions, and can include seizures, cognitive decline, visual impairment, speech difficulties, and motor deficits like spasticity or paralysis, leading to significant neurological dysfunction. While it can mimic multiple sclerosis due to its demyelinating nature, Schilder's disease typically features larger, more diffuse lesions and a more aggressive course. Its exact cause remains unknown, though an autoimmune component is suspected.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute to subacute, typically developing over days to weeks.
Duration of Illness (Lifetime)
Chronic and progressive, often leading to severe disability or death within years; some atypical cases may have a more relapsing-remitting course.
Cost of Treatment (Initial)
High (involving hospitalization, extensive diagnostics, and acute therapies).
Cost of Treatment (Lifetime)
Very high (due to long-term management, rehabilitation, and potential ongoing care for severe disability).
Mortality Rate
Significant (estimated 20-50% within 5-10 years, especially in severe childhood-onset forms, though variable).
Risk of Secondary Damages
Very high (e.g., >90% likelihood of permanent neurological deficits including cognitive impairment, motor disability, visual loss, and epilepsy).
Probability of Full Recovery
Low (<10%, with most experiencing partial recovery with residual deficits; complete recovery is exceedingly rare).
Underlying Disease Risk
Low for other distinct underlying diseases causing it; however, it is often a diagnosis of exclusion and can be misdiagnosed or overlap with other demyelinating conditions like Multiple Sclerosis (MS) or other leukodystrophies.